Your browser doesn't support javascript.
loading
Comparison between brodalumab, secukinumab and ixekizumab effectiveness and drug survival: A real-life experience on 638 patients with psoriasis.
Mastorino, Luca; Cariti, Caterina; Susca, Sara; Siliquini, Niccolò; Verrone, Anna; Stroppiana, Elena; Ortoncelli, Michela; Dapavo, Paolo; Quaglino, Pietro; Ribero, Simone.
  • Mastorino L; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
  • Cariti C; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
  • Susca S; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
  • Siliquini N; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
  • Verrone A; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
  • Stroppiana E; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
  • Ortoncelli M; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
  • Dapavo P; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
  • Quaglino P; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
  • Ribero S; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
Exp Dermatol ; 32(9): 1591-1594, 2023 09.
Article en En | MEDLINE | ID: mdl-37395012
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Psoriasis / Anticuerpos Monoclonales Humanizados Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Psoriasis / Anticuerpos Monoclonales Humanizados Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article